$MORPHO has shown tremendous growth this year, climbing to $7B in TVL.


But what's interesting is that $AAVE and $SYRUP are quietly leading the segment across several metrics.
Let's compare $AAVE vs $MORPHO vs $SYRUP on everything that counts, leading and lagging indicators.👇
➨ LEADING INDICATORS (what moves before the price does)
1⃣Utilization Rate (how hard each deposit base actually works)
SYRUP: 46.7%
AAVE: 44.2%
MORPHO: 34.5%
Maple runs the tightest book in the category. Nearly half its deposits are actively lent out. Morpho's lower number is structural, its curator-driven markets don't deploy all liquidity at once.
2⃣Net Deposit Flows (30d)
SYRUP: +0.8%
MORPHO: −6.5%
AAVE: −7.7%
Maple is the only one of the three taking in capital right now. Aave and Morpho are contracting in near-lockstep, which reads as market-wide deleveraging, not a problem with either protocol.
3⃣ Revenue Mix (who actually gets the fees)
AAVE: 87% to LPs, 13% to protocol
SYRUP: 88% to LPs, 12% to protocol
MORPHO: 100% to LPs, 0% to protocol
Morpho keeps nothing for its treasury. The fee switch isn't on yet. Excellent for depositors. Hollow for token holders, for now. Hold that thought.
➨ LAGGING INDICATORS (what confirms a move already happened)
4⃣Fees Generated (30d / annualized)
AAVE: $41.1M / $938.9M
MORPHO: $19.7M / $205.0M
SYRUP: $9.2M / $103.6M
Aave isn't just leading here, it's printing ~5x Maple. But watch the direction: fee growth is Maple +28%, Morpho +28%, Aave roughly flat (the ugly −40% headline is distorted by a one-off May 6 liquidation spike in the prior window). The smaller two are compounding.
5⃣TVL
AAVE: $12.80B
MORPHO: $6.91B
SYRUP: $2.08B
Aave still holds ~2x Morpho and ~6x Maple. Size is real.
6⃣Market Cap & Valuation
AAVE: $1.11B mcap, 1.2x price-to-fees
MORPHO: $1.26B mcap, 6.2x price-to-fees
SYRUP: $161M mcap, 1.6x price-to-fees
Which of these DeFi lending projects are you backing for the rest of 2026? 🤔
MORPHO-1.28%
AAVE1.85%
SYRUP0.22%
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned